16 June 2020: Clinical Research
Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis
Dongdong Yuan 1ABCD , Xiangfen Shi 2BCD , Liping Guo 1BF , Gaobiao Wang 1BF , Yujie Zhao 1B , Yuling Yang 1B , Hanjuan Zhang 1B , Qiong Huang 1B , Yiqiang Yuan 1AE*DOI: 10.12659/MSM.923758
Med Sci Monit 2020; 26:e923758
Table 4 Distribution of arachidonic acid-induced platelet aggregation rates in patients without reported bleeding events.
| ACA-induced platelet aggregation (%) | Patients (n=25) | % |
|---|---|---|
| 50–30 | 7 | 30 |
| 50–25 | 11 | 45 |
| 50–20 | 15 | 60 |
| 50–18 | 20 | 80 |
| 50–5 | 25 | 100 |
| ACA – arachidonic acid. | ||